Intelligent Ultrasound Group Full Year 2022 Earnings: Beats Expectations

Simply Wall St

April 21, 2023

Intelligent Ultrasound Group (LON:IUG) Full Year 2022 Results

Key Financial Results

Revenue: UK£10.1m (up 33% from FY 2021).
Net loss: UK£2.98m (loss narrowed by 17% from FY 2021).
UK£0.011 loss per share (improved from UK£0.013 loss in FY 2021).

earnings-and-revenue-growth — AIM:IUG Earnings and Revenue Growth April 21st 2023

All figures shown in the chart above are for the trailing 12 month (TTM) period

Intelligent Ultrasound Group Revenues and Earnings Beat Expectations

Revenue exceeded analyst estimates by 1.2%. Earnings per share (EPS) also surpassed analyst estimates by 6.1%.

Looking ahead, revenue is forecast to grow 28% p.a. on average during the next 2 years, compared to a 11% growth forecast for the Healthcare Services industry in the United Kingdom.

Performance of the British Healthcare Services industry.

The company's shares are up 47% from a week ago.

Risk Analysis

Before you take the next step you should know about the 3 warning signs for Intelligent Ultrasound Group (1 doesn't sit too well with us!) that we have uncovered.

If you're looking to trade Intelligent Ultrasound Group, open an account with the lowest-cost platform trusted by professionals, Interactive Brokers.

With clients in over 200 countries and territories, and access to 160 markets, IBKR lets you trade stocks, options, futures, forex, bonds and funds from a single integrated account.

Enjoy no hidden fees, no account minimums, and FX conversion rates as low as 0.03%, far better than what most brokers offer.

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.